The Research of Standard Diagnosis and Treatment for Severe HSP in Children

Phase 2 Unknown 30 enrolled Nanjing Children's Hospital

RandomizedParallel-groupSingle-blindTreatment

This study is performed to evaluate the efficacy and safety of various measures in the treatment of severe HSP in children.

Evaluation	Drug	Modality	Dose	Route
Subject	Immune Globulin Intravenous (Human)	Protein / enzyme biologic	2 g/kg	Intravenous
Background	Dexamethasone	Small molecule	0.5 mg/kg	Intravenous